Kazia Therapeutics (KZIA) Equity Ratio (2009 - 2025)

Kazia Therapeutics has reported Equity Ratio for 14 years, with the latest figure at 0.65 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio changed N/A year-over-year to 0.65; the trailing twelve-month figure through Dec 2025 stood at 0.65 (changed N/A YoY), and the FY2025 full-year result was 1.37, down 195.21% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.65, up from 1.37 in the prior quarter.
• The five-year high for Equity Ratio was 0.65 in Q4 2025, with the low at 1.37 in Q2 2025.
• Historically, Equity Ratio has averaged 0.18 across 5 years, with a median of 0.43 in 2023.
• Annual changes were most pronounced in 2021 — Equity Ratio grew 6.4% — and 2024, when it sank 208.16%.
• Kazia Therapeutics' Equity Ratio stood at 0.57 in 2021, then decreased by 27.09% to 0.42 in 2022, then plunged by 48.09% to 0.22 in 2023, then slumped by 314.82% to 0.46 in 2024, then jumped by 240.81% to 0.65 in 2025.
• The last three Equity Ratio figures came in at 0.65 (Q4 2025), 1.37 (Q2 2025), and 0.46 (Q2 2024), per Business Quant data.